Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Global Cannabis eyes emerging markets with FOCUS collaboration

Stockhouse Editorial
0 Comments| April 17, 2018

{{labelSign}}  Favorites
{{errorMessage}}

Global Cannabis Applications Corp. (CSE: C.APP, OTCQB: FUAPF, Forum) said Tuesday it has signed a collaboration agreement with the Foundation of Cannabis United Standards to establish legal cannabis programs in emerging markets and increase patient efficacy data supply, with the ultimate goal of increasing health and safety.

Foundation of Cannabis Unified Standards (FOCUS) was established in 2014 as the Cannabis Health and Safety Organization in an effort to protect public health, consumer safety, and safeguard the environment. FOCUS is a global non-profit, with international operations in the U.S., Mexico, Canada, Australia, Columbia and New Zealand.

More information can be found here.

published a White Paper on its medical cannabis Citizen Green technology platform and token economy.

The White Paper is available for download at www.cannappscorp.corp.

The announcement comes after Global Cannabis said it will participate in a medical cannabis study on the effects of cannabis on mental health conducted by Dr. Alasdair Barr.

The study, to be conducted at the University of British Columbia, will be applied using semi-structured clinical interviews with instruments commonly applied to clinical trials in order to investigate a population of people in Vancouver, B.C, who suffer from metal health issues and choose to self-medicate with medical cannabis.

Global Cannabis was also in the news recently when it announced the launch of Global Cannabis Apps Corp. (GCAC), a private Australian company held 61% by Global Cannabis, which in turn is based in Vancouver.

FULL DISCLOSURE: Global Cannabis Applications Corp. is a paid client of Stockhouse Publishing.


{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company